迈克生物,300463,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 自主产品,66355,14901,51454,77.54%,67.71% 其他(补充),2228,329,1899,85.23%,2.5% 代理产品,76664,54027,22638,29.53%,29.79% 迈克生物,300463,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 自主产品,121602,26079,95523,78.55%,57.2% 其他(补充),3370,491,2879,85.42%,1.72% 代理产品,197323,128724,68599,34.76%,41.08% 迈克生物,300463,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1573,131,1442,91.67%,1.79% 自产仪器,1029,782,248,24.07%,0.31% 代理仪器,8780,5712,3068,34.94%,3.81% 自产试剂,53970,9904,44066,81.65%,54.72% 代理试剂,86370,54670,31701,36.7%,39.37% 迈克生物,300463,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2917,269,2648,90.78%,1.9% 自产试剂,96100,18821,77278,80.41%,55.55% 代理试剂,145900,91535,54366,37.26%,39.08% 代理仪器,21022,16944,4078,19.4%,2.93% 自产仪器,2592,1860,732,28.26%,0.53% 迈克生物,300463,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 自产仪器,1047,797,250,23.86%,0.39% 代理试剂,67476,42426,25050,37.12%,38.64% 自产试剂,44455,8066,36389,81.86%,56.13% 其他(补充),1429,122,1307,91.47%,2.02% 代理仪器,10237,8401,1836,17.93%,2.83% 迈克生物,300463,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2186,148,2038,93.24%,2.03% 代理仪器,18389,-- ,-- ,--,0% 自产试剂,75919,16277,59642,78.56%,59.44% 代理试剂,98721,60066,38655,39.16%,38.53% 自产仪器,1783,-- ,-- ,--,0% 迈克生物,300463,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),724,39,685,94.67%,1.55% 代理试剂,42797,25837,16959,39.63%,38.26% 代理仪器,6402,4997,1405,21.95%,3.17% 自产试剂,33395,8492,24903,74.57%,56.18% 自产仪器,1003,632,371,36.99%,0.84% 迈克生物,300463,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2033,166,1867,91.84%,2.32% 代理仪器,11784,8888,2895,24.57%,3.6% 代理试剂,76465,44336,32129,42.02%,39.89% 自产仪器,1664,1116,548,32.93%,0.68% 自产试剂,56932,13835,43098,75.7%,53.51% 迈克生物,300463,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),968,170,798,82.41%,2.2% 代理仪器,6067,4683,1384,22.82%,3.81% 代理试剂,34477,19409,15069,43.71%,41.47% 自产仪器,477,346,131,27.53%,0.36% 自产试剂,24912,5957,18955,76.09%,52.16% 迈克生物,300463,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),823,104,719,87.4%,1.18% 代理仪器,9473,7179,2294,24.22%,3.78% 代理试剂,43883,22598,21285,48.5%,35.08% 自产仪器,6690,4419,2271,33.95%,3.74% 自产试剂,45649,11541,34108,74.72%,56.21% 迈克生物,300463,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理仪器,5461,4201,1261,23.09%,4.35% 自产试剂,21293,5574,15719,73.82%,54.23% 代理试剂,20945,10269,10675,50.97%,36.83% 其他(补充),301,61,240,79.67%,0.83% 自产仪器,3442,2351,1091,31.7%,3.76% 迈克生物,300463,收入构成,报告日期,2015-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),111,22,90,80.57%,0.76% 自产仪器,1023,642,381,37.21%,3.24% 代理仪器,2429,1796,633,26.04%,5.39% 自产试剂,8254,2273,5981,72.46%,50.97% 代理试剂,9003,4354,4649,51.64%,39.63% 迈克生物,300463,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理仪器,10309,6811,3498,33.93%,6.32% 其他(补充),1530,163,1367,89.35%,2.47% 自产仪器,4960,3165,1795,36.19%,3.24% 自产试剂,36526,8936,27590,75.53%,49.81% 代理试剂,40159,19017,21142,52.65%,38.17% 迈克生物,300463,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理仪器,12822,8850,3972,30.98%,9.04% 自产试剂,29696,8384,21312,71.77%,48.51% 代理试剂,32478,15437,17041,52.47%,38.79% 其他(补充),1159,146,1013,87.38%,2.31% 自产仪器,1788,1196,592,33.11%,1.35% 迈克生物,300463,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),894,170,723,80.96%,2.13% 代理仪器,11197,7382,3815,34.07%,11.23% 自产试剂,23029,6938,16090,69.87%,47.36% 代理试剂,25397,12095,13301,52.37%,39.15% 自产仪器,100,55,45,44.74%,0.13%